Pfizer was among the 17 companies that received a July 31 letter from president Donald Trump demanding lower drug prices. Pfizer maintained its full-year revenue forecast, but raised its full-year ...

Pfizer (PFE) increased its 2025 profit outlook by 10 cents a share to a range of $2.90 to $3.10 a share, citing continued cost cuts, a lower tax rate and "confidence" that strength seen in the first ...

STORY: Pfizer raised its full-year profit forecast on Tuesday (August 5).It said it expects to benefit from cost-cutting and ...

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Aug 5 - Pfizer (NYSE:PFE) heads into its Q2 earnings release amid growing investor caution. Analysts expect revenue around ...

Pfizer increased its 2025 profit outlook by 10 cents a share to a range of $2.90 a share to $3.10 a share, citing continued cost cuts, a lower tax rate and “confidence” that strength seen in the first ...

Pfizer has said it has enough manufacturing capacity across its 10 U.S. sites to mitigate any tariff impact and is open to shifting some production to those facilities. Total quarterly sales of $14.65 ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

As part of its Q2 print, Pfizer raised its forward guidance, saying it now expects a full-year profit of $2.90 U.S. to $3.10 U.S., up from a previous outlook of $2.80 U.S. to $3 U.S. a share.